Invention Grant
US08633205B2 Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases
失效
取代的吡咯并[2,3-d]嘧啶作为蛋白激酶的抑制剂
- Patent Title: Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases
- Patent Title (中): 取代的吡咯并[2,3-d]嘧啶作为蛋白激酶的抑制剂
-
Application No.: US11346048Application Date: 2006-02-02
-
Publication No.: US08633205B2Publication Date: 2014-01-21
- Inventor: Mark Ledeboer , Albert Pierce , Guy Bemis , Luc Farmer , Tiansheng Wang , David Messersmith , John Duffy , Francesco Salituro , Jian Wang
- Applicant: Mark Ledeboer , Albert Pierce , Guy Bemis , Luc Farmer , Tiansheng Wang , David Messersmith , John Duffy , Francesco Salituro , Jian Wang
- Applicant Address: US MA Cambridge
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Cambridge
- Agent Lisa A. Dixon; Susan C. Kelly
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/519 ; A61K31/497 ; A61P35/00 ; A61P37/06 ; A61P25/28
![Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein kinases](/abs-image/US/2014/01/21/US08633205B2/abs.jpg.150x150.jpg)
Abstract:
The present invention relates to compounds of the following formula: which are useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Public/Granted literature
- US20070004762A9 Pyrrolopyrimidines useful as inhibitors of protein kinase Public/Granted day:2007-01-04
Information query